Literature DB >> 1315532

Marine sponge polyketide inhibitors of protein tyrosine kinase.

R H Lee1, D L Slate, R Moretti, K A Alvi, P Crews.   

Abstract

The marine polyketide natural product, halenaquinone, was shown to be an irreversible inhibitor of pp60v-src, the oncogenic protein tyrosine kinase encoded by the Rous sarcoma virus. This compound had an IC50 of approximately 1.5 microM against pp60v-src and also inhibited the ligand-stimulated kinase activity of the human epidermal growth factor receptor with an IC50 of approximately 19 microM. Halenaquinone blocked the proliferation of a number of cultured cell lines, including several transformed by oncogenic protein tyrosine kinases. Halenaquinol, xestoquinone, halenaquinol sulfate, and several simple synthetic quinone analogs were also shown to inhibit pp60v-src.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1315532     DOI: 10.1016/0006-291x(92)90656-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Neopetrosiquinones A and B, sesquiterpene benzoquinones isolated from the deep-water sponge Neopetrosia cf. proxima.

Authors:  Priscilla L Winder; Heather L Baker; Patricia Linley; Esther A Guzmán; Shirley A Pomponi; M Cristina Diaz; John K Reed; Amy E Wright
Journal:  Bioorg Med Chem       Date:  2011-09-21       Impact factor: 3.641

2.  Anticancer activity of Turkish marine extracts: a purple sponge extract induces apoptosis with multitarget kinase inhibition activity.

Authors:  Halil I Ciftci; Mustafa Can; Doha E Ellakwa; Salih C Suner; Mohamed A Ibrahim; Ayhan Oral; Nazim Sekeroglu; Barış Özalp; Masami Otsuka; Mikako Fujita; Mustafa Alparslan; Mohamed O Radwan
Journal:  Invest New Drugs       Date:  2020-02-15       Impact factor: 3.850

3.  Strategies for the Synthesis of the Halenaquinol and Xestoquinol Families of Natural Products.

Authors:  Gregg M Schwarzwalder; Christopher D Vanderwal
Journal:  European J Org Chem       Date:  2017-02-16

Review 4.  Recent Developments Using Small Molecules to Target RAD51: How to Best Modulate RAD51 for Anticancer Therapy?

Authors:  Brian Budke; Wei Lv; Alan P Kozikowski; Philip P Connell
Journal:  ChemMedChem       Date:  2016-10-26       Impact factor: 3.466

Review 5.  Mechanism targeted discovery of antitumor marine natural products.

Authors:  Dale G Nagle; Yu-Dong Zhou; Flor D Mora; Kaleem A Mohammed; Yong-Pil Kim
Journal:  Curr Med Chem       Date:  2004-07       Impact factor: 4.530

Review 6.  Kinase inhibitors from marine sponges.

Authors:  Danielle Skropeta; Natalie Pastro; Ana Zivanovic
Journal:  Mar Drugs       Date:  2011-10-24       Impact factor: 6.085

7.  Identification of Natural Products That Inhibit the Catalytic Function of Human Tyrosyl-DNA Phosphodiesterase (TDP1).

Authors:  Alun Bermingham; Edmund Price; Christophe Marchand; Adel Chergui; Alena Naumova; Emily L Whitson; Lauren R H Krumpe; Ekaterina I Goncharova; Jason R Evans; Tawnya C McKee; Curtis J Henrich; Yves Pommier; Barry R O'Keefe
Journal:  SLAS Discov       Date:  2017-07-11       Impact factor: 3.341

8.  Tackling the Cytotoxic Effect of a Marine Polycyclic Quinone-Type Metabolite: Halenaquinone Induces Molt 4 Cells Apoptosis via Oxidative Stress Combined with the Inhibition of HDAC and Topoisomerase Activities.

Authors:  Shou-Ping Shih; Man-Gang Lee; Mohamed El-Shazly; Yung-Shun Juan; Zhi-Hong Wen; Ying-Chi Du; Jui-Hsin Su; Ping-Jyun Sung; Yu-Cheng Chen; Juan-Cheng Yang; Yang-Chang Wu; Mei-Chin Lu
Journal:  Mar Drugs       Date:  2015-05-20       Impact factor: 5.118

Review 9.  Sponges: A Reservoir of Genes Implicated in Human Cancer.

Authors:  Helena Ćetković; Mirna Halasz; Maja Herak Bosnar
Journal:  Mar Drugs       Date:  2018-01-10       Impact factor: 5.118

Review 10.  Marine Sponges and Bacteria as Challenging Sources of Enzyme Inhibitors for Pharmacological Applications.

Authors:  Nadia Ruocco; Susan Costantini; Flora Palumbo; Maria Costantini
Journal:  Mar Drugs       Date:  2017-06-12       Impact factor: 5.118

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.